Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-11-001374

CEO bought 7,500 shares at $0.60 ($4,500)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2011-12-07 Purchase : show line 1 in the form +7,500 $0.60 $4,500 12,500 D
Open-market purchases · 7,500 sh · avg $0.60 · $4,500
Loading xslF345X03/form4-12082011_101235.xml…